Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports. In addition, the company provides respiratory care products, such as closed suction catheters and endotracheal tubes; vascular access products comprising angiographic catheters, PTA balloon dilatation catheters, sheath introducers, guidewires, high pressure connecting tubes, PTCA balloon dilatation catheter-rapid exchange products, manifolds, and Y connectors; and medical components, including dialyzer connectors and caps, recirculating connectors with cap, rotating luer lock connectors, pump and T connectors, female luers, injection sites, luer lock and chamber caps, drip chambers, filters, clamps, pressure pillows, safeline HDF components, chamber assembly, and transducer protectors, as well as medical masks. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.
Taiwanese Market Performance
7D7 Days: -0.1%
3M3 Months: 13.5%
1Y1 Year: 16.0%
YTDYear to Date: 1.8%
The market has been flat over the last week. More promisingly, the market is up 16% over the past year. Earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.